Back to mobile site

Benchmark Almost Doubles Their Price Target on STAAR Surgical (STAA), Maintains Buy Rating

January 12, 2011 8:58 AM EST Send to a Friend
Benchmark is maintaining their Buy rating on shares of STAAR Surgical (NASDAQ: STAA) as the company is inline for approval ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login